Benedetta Belloni
Overview
Explore the profile of Benedetta Belloni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
513
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Cheng P, Shakhova O, Widmer D, Eichhoff O, Zingg D, Frommel S, et al.
Genome Biol
. 2015 Apr;
16:42.
PMID: 25885555
Background: Melanoma is the most fatal skin cancer displaying a high degree of molecular heterogeneity. Phenotype switching is a mechanism that contributes to melanoma heterogeneity by altering transcription profiles for...
3.
Schoenewolf N, Belloni B, Simcock M, Tonolla S, Vogt P, Scherrer E, et al.
Eur J Dermatol
. 2014 Apr;
24(2):236-41.
PMID: 24721680
Background: The incidence and mortality of malignant melanoma have been rising during the past decades, the latter being due to the high invasion capacity and the metastatic potential of melanoma...
4.
Rinderknecht J, Goldinger S, Rozati S, Kamarashev J, Kerl K, French L, et al.
PLoS One
. 2013 Mar;
8(3):e58721.
PMID: 23516541
Purpose: Vemurafenib is a potent inhibitor of V600 mutant BRAF with significant impact on progression-free and overall survival in advanced melanoma. Cutaneous side effects are frequent. This single-center observational study...
5.
Walter A, Schafer M, Cecconi V, Matter C, Urosevic-Maiwald M, Belloni B, et al.
Nat Commun
. 2013 Mar;
4:1560.
PMID: 23463003
Aldara is a cream used for topical treatment of non-melanoma skin cancer, and is thought to act through stimulation of anti-tumour immunity. The active ingredient, imiquimod, has been shown to...
6.
Belloni B, Lambertini C, Nuciforo P, Phillips J, Bruening E, Wong S, et al.
J Clin Pathol
. 2012 Nov;
66(2):124-35.
PMID: 23125305
Unlabelled: Formalin fixation and paraffin embedding present the standard procedures for conserving clinical tissues for histological analysis. However, molecular analysis is impaired by the cross linking properties of formalin. The...
7.
Zirbs M, Belloni B, Ring J, Andres C
Int J Dermatol
. 2012 Jul;
52(9):1154-5.
PMID: 22804489
No abstract available.
8.
Belloni B, Schonewolf N, Rozati S, Goldinger S, Dummer R
Chem Immunol Allergy
. 2012 May;
97:191-202.
PMID: 22613863
There is a variety of adverse effects and toxicities of newer and older chemotherapeutic agents which emerge in the skin, mucosa and adnexa. Common skin reactions while undergoing chemotherapy include...
9.
Belloni B, Johansen N, Glass L, Dummer R
Semin Oncol
. 2012 Apr;
39(2):150-62.
PMID: 22484187
The treatment options for patients with primary cutaneous B- and T-cell lymphomas are as diverse as the diseases themselves, including both skin-directed and systemic therapies. Long-term remission can be attained...
10.
Schoenewolf N, Bull C, Belloni B, Holzmann D, Tonolla S, Lang R, et al.
Eur J Cancer
. 2012 Apr;
48(12):1842-52.
PMID: 22464346
KIT aberrations predict the outcome of targeted therapies in acrolentiginous (ALM) and mucosal (MM) melanoma patients. KIT immunoreactivity and mutation status was assessed in 41 ALM and 25 MM patients....